Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on October 21, 2025

October 21, 2025

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout

GlobeNewswire

October 21, 2025

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

GlobeNewswire

October 21, 2025

SS Innovations to Participate in Upcoming Investor Conferences

GlobeNewswire

October 21, 2025

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

GlobeNewswire

October 21, 2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

GlobeNewswire

October 21, 2025

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®

GlobeNewswire

October 21, 2025

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

GlobeNewswire

October 21, 2025

BIO-key Introduces EcoID III USB Fingerprint Scanner Delivering FBI FAP 20 Certification, Security, Liveness Detection, and Encrypted Device-to-Host Communication

GlobeNewswire

October 21, 2025

MediBeacon receives regulatory approval to sell the Transdermal GFR System in China

GlobeNewswire

October 21, 2025

Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025

GlobeNewswire

October 21, 2025

InnovAge to Announce Fiscal First Quarter 2026 Financial Results and Host Conference Call Tuesday, November 4, 2025

GlobeNewswire

October 21, 2025

Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET

GlobeNewswire

October 21, 2025

Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025

GlobeNewswire

October 21, 2025

Medical Specialists of the Palm Beaches Unveils State-of-the-Art Medical Facility in Wellington, Florida

GlobeNewswire

October 21, 2025

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week

GlobeNewswire

October 21, 2025

Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025

GlobeNewswire

October 21, 2025

Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook

GlobeNewswire

October 21, 2025

Simcha Therapeutics Presents Preclinical Data Demonstrating Potential for Decoy-Resistant IL-18 to Enhance Efficacy of Bi-specific T-cell Engagers

GlobeNewswire

October 21, 2025

Konica Minolta Healthcare Receives Innovative Technology Designation from Vizient for Dynamic Digital Radiography

GlobeNewswire

October 21, 2025

NIH Grant Awarded to Further Research of Novel Chemical Pathway to Reverse MCI

GlobeNewswire